Drug intelligence / Profile preview

PRIC

Development stage: Unknown

Overview

PRIC is a drug that was investigated in a safety and pharmacokinetic study (NCT03826485) in healthy adult subjects. The study aimed to compare its pharmacokinetic profile with Pranlukast Dry Syrup and evaluate its safety and tolerability. Further details regarding its mechanism of action or primary indication are not available in the provided context.

Beyond the preview

Go deeper on PRIC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRIC.

Explore the full profile